Table 1 Baseline characteristics of HT patients
Items | Training set | P-value | Internal test set | P-value | External test set | P-value | |||
|---|---|---|---|---|---|---|---|---|---|
CHT(n= 50) | Seronegative HT(n= 42) | CHT(n= 9) | Seronegative HT(n= 9) | CHT(n= 12) | Seronegative HT(n= 12) | ||||
Female/Male | 47/3 | 41/1 | 0.40 | 8/1 | 9/0 | 0.50 | 11/1 | 12/0 | 0.50 |
Age(years) | 48.4 ± 13.1 | 53.7 ± 9.6 | 0.05 | 51.3 ± 12.7 | 54.1 ± 8.3 | 0.01 | 44.2 ± 16.7 | 55.5 ± 8.3 | 0.01 |
FT3(pg/ml) | 3.35 ± 0.74 | 3.24 ± 0.43 | 0.09 | 3.15 ± 0.24 | 3.41 ± 0.57 | 0.13 | 3.74 ± 1.15 | 3.01 ± 0.41 | 0.08 |
FT4(ng/dl) | 1.23 ± 0.22 | 1.29 ± 0.23 | 0.39 | 1.14 ± 0.09 | 1.27 ± 0.21 | 0.04 | 1.32 ± 0.29 | 1.26 ± 0.26 | 0.76 |
TSH(μU/ml) | 3.10 ± 3.63 | 2.22 ± 1.23 | 0.02 | 3.47 ± 2.77 | 1.57 ± 1.00 | 0.13 | 3.12 ± 4.02 | 2.76 ± 0.89 | 0.09 |
TPOAb(U/ml) | 557.81 ± 530.12 | 37.18 ± 11.86 | 0.00 | 1038.96 ± 385.41 | 35.49 ± 8.65 | 0.00 | 136.87 ± 138.76 | 37.69 ± 13.72 | 0.02 |
TGAb(U/ml) | 242.18 ± 194.71 | 20.75 ± 14.87 | 0.00 | 252.51 ± 196.84 | 27.07 ± 20.08 | 0.00 | 347.56 ± 231.57 | 20.64 ± 14.09 | 0.00 |